ALK-Abelló A/S (OTC:AKBLF – Get Free Report) shares traded up 2.1% on Monday . The stock traded as high as $24.50 and last traded at $24.50. 5 shares traded hands during trading, a decline of 99% from the average session volume of 618 shares. The stock had previously closed at $24.00.
ALK-Abelló A/S Trading Down 2.9 %
The firm’s 50 day moving average is $25.22 and its two-hundred day moving average is $22.73.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Articles
- Five stocks we like better than ALK-Abelló A/S
- CD Calculator: Certificate of Deposit Calculator
- Rocket Lab is the Right Stock for the Right Time
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What to Know About Investing in Penny Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
